1
Clinical Trials associated with Autologous Mesenchymal Stromal Cells(Karolinska University Hospital)An Open Phase I/II Study in Patients With Dysphonia and Vocal Fold Scarring to Evaluate Safety, Tolerability and Vocal Function After Surgery With Local Administration of Autologous Mesenchymal Stromal Cells
The overall aim of the project is to develop a new method for treatment of untreatable severe hoarseness due to vocal fold scarring by local injection of autologous mesenchymal stromal cells (MSC). At present there is no lasting effective treatment for this condition which results in personal suffering, and often extended sick leave, change of work or unemployement for the patients.
Based on the previous results the investigators expect the autologous MSC product KI-MSC-PL-204 to be a new effective treatment without side effects for many patients with severe hoarseness or aphonia due to vocal fold scarring.
100 Clinical Results associated with Autologous Mesenchymal Stromal Cells(Karolinska University Hospital)
100 Translational Medicine associated with Autologous Mesenchymal Stromal Cells(Karolinska University Hospital)
100 Patents (Medical) associated with Autologous Mesenchymal Stromal Cells(Karolinska University Hospital)
100 Deals associated with Autologous Mesenchymal Stromal Cells(Karolinska University Hospital)